Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype.
Wagner K, Damm F, Thol F, Göhring G, Görlich K, Heuser M, Schäfer I, Schlegelberger B, Heil G, Ganser A, Krauter J. Wagner K, et al. Among authors: heil g. Haematologica. 2011 May;96(5):681-6. doi: 10.3324/haematol.2010.034074. Epub 2011 Jan 17. Haematologica. 2011. PMID: 21242187 Free PMC article. Clinical Trial.
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W, Haas R, Kuse R, et al. Freund M, et al. Among authors: heil g. Cancer. 1992 Feb 1;69(3):709-16. doi: 10.1002/1097-0142(19920201)69:3<709::aid-cncr2820690318>3.0.co;2-g. Cancer. 1992. PMID: 1730121
Leukemic cells on melamine substrate foils.
Westphal C, Krauter J, Heil G. Westphal C, et al. Among authors: heil g. In Vitro Cell Dev Biol. 1991 Aug;27A(8):597-8. doi: 10.1007/BF02631100. In Vitro Cell Dev Biol. 1991. PMID: 1917775 No abstract available.
Treatment of relapsed acute lymphocytic leukemia in adults.
Freund M, De Boben M, Diedrich H, Ganser A, Heil G, Heyll A, Henke M, Hiddemann W, Knauf U, Koch P, et al. Freund M, et al. Among authors: heil g. Haematol Blood Transfus. 1990;33:432-6. doi: 10.1007/978-3-642-74643-7_80. Haematol Blood Transfus. 1990. PMID: 2182434 Clinical Trial.
[Intensive combined therapy for high-risk ALL patients].
Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Kurrle E, Heimpel H, Koch P, Lipp T, et al. Hoelzer D, et al. Among authors: heil g. Onkologie. 1988 Feb;11(1):18-24. doi: 10.1159/000216474. Onkologie. 1988. PMID: 3283621 Clinical Trial. German.
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results.
Ganser A, Heil G, Kolbe K, Maschmeyer G, Fischer JT, Bergmann L, Mitrou PS, Heit W, Heimpel H, Huber C, et al. Ganser A, et al. Among authors: heil g. Ann Hematol. 1993 Mar;66(3):123-5. doi: 10.1007/BF01697620. Ann Hematol. 1993. PMID: 7682447 Clinical Trial.
198 results